| Date | Form | Description | Docs | XBRL | Pages |
| 06/16/14 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
63 |
| 06/13/14 | UPLOAD | SEC-generated letter |
|
2 | |
| 06/03/14 | PRE 14A | Preliminary proxy statement not related to a contested matter or merger/acquisition |
|
48 | |
| 05/30/14 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 05/08/14 | EFFECT | Notice of Effectiveness |
|
1 | |
| 05/06/14 | CORRESP | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. |
|
1 | |
| 05/06/14 | S-3/A | Registration statement for specified transactions by certain issuers |
|
29 | |
| 04/30/14 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 04/25/14 | EFFECT | Notice of Effectiveness |
|
1 | |
| 04/23/14 | CORRESP | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. |
|
1 |
Latest News & Events
Anixa Biosciences to Present at the iAccess Alpha Virtual Best Ideas Winter Conference 2024 on December 10
Read More...Anixa Biosciences Board of Directors Approves Purchase of Bitcoin as Treasury Reserve Asset
Read More...Anixa Biosciences Initiates Dosing in Third Cohort in its Ovarian Cancer CAR-T Clinical Trial
Read More...